ResearcherMayo ClinicNo recent work listed
John R. Ogden
Matched on ORCID iD 0000-0002-7738-5055; OpenAlex author ID A5076261794. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2018: 1 paper · 2019: none · 2020: 2 papers
Papers 3
- Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/coc.0000000000000708↗
- Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1634/theoncologist.2020-0086↗
- The Management of Older Adults with Pancreatic Adenocarcinoma. Co-author DOI 10.3390/geriatrics3040085↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Joleen Marie Hubbard · 3 shared papers, 2018–2020 · strength 0.32
- Paper The Management of Older Adults with Pancreatic Adenocarcinoma. DOI 10.3390/geriatrics3040085↗
- Paper Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1097/coc.0000000000000708↗
- Paper Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1634/theoncologist.2020-0086↗
- Hao Xie · 3 shared papers, 2018–2020 · strength 0.32
- Paper The Management of Older Adults with Pancreatic Adenocarcinoma. DOI 10.3390/geriatrics3040085↗
- Paper Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1097/coc.0000000000000708↗
- Paper Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1634/theoncologist.2020-0086↗
- Wen Wee Ma · 3 shared papers, 2018–2020 · strength 0.32
- Paper The Management of Older Adults with Pancreatic Adenocarcinoma. DOI 10.3390/geriatrics3040085↗
- Paper Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1097/coc.0000000000000708↗
- Paper Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1634/theoncologist.2020-0086↗
- Aminah Jatoi · 2 shared papers, 2020 · strength 0.21
- Paper Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1097/coc.0000000000000708↗
- Paper Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1634/theoncologist.2020-0086↗
- Tanios Bekaii‐Saab · 2 shared papers, 2020 · strength 0.21
- Paper Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1097/coc.0000000000000708↗
- Paper Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1634/theoncologist.2020-0086↗
- Gloria M. Petersen · 2 shared papers, 2020 · strength 0.21
- Paper Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1097/coc.0000000000000708↗
- Paper Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1634/theoncologist.2020-0086↗
- Robert R. McWilliams · 2 shared papers, 2020 · strength 0.21
- Paper Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1097/coc.0000000000000708↗
- Paper Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1634/theoncologist.2020-0086↗
- Amit Mahipal · 2 shared papers, 2020 · strength 0.21
- Paper Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1097/coc.0000000000000708↗
- Paper Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1634/theoncologist.2020-0086↗
- Mark Joseph Truty · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.